Browsing Over 180 Presentations
Sort By
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Industry Satellite Symposia
Adjuvant therapy for patients with HR+/HER2- EBC at high risk of recurrence (ID 338)
Lecture Time
19:15 - 19:30
Speakers
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Industry Satellite Symposia
Summary and close (ID 344)
Lecture Time
16:55 - 17:00
Speakers
Session Name
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Industry Satellite Symposia
Chair introduction (ID 340)
Lecture Time
16:00 - 16:05
Speakers
Session Name
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Industry Satellite Symposia
Improved patient outcomes with next-generation HER2-targeted ADCs (ID 341)
Lecture Time
16:20 - 16:35
Speakers
Session Name
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Industry Satellite Symposia
Panel discussion and Q&A (ID 342)
Lecture Time
16:35 - 16:55
Speakers
Session Name
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Industry Satellite Symposia
Unmet needs in advanced/metastatic HER2-positive breast cancer (ID 343)
Lecture Time
16:05 - 16:20
Speakers
Session Name
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00
Seagen - Research to reality: Going further for patients with HER2+ metastatic breast cancer
Industry Satellite Symposia
Key considerations for patients with brain metastases (ID 361)
Lecture Time
17:47 - 17:55
Speakers
Session Name
Room
Channel 2
Date
Thu, 06.05.2021
Time
17:30 - 18:30
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world
Industry Satellite Symposia
Welcome and introduction (ID 345)
Lecture Time
17:30 - 17:35
Speakers
Room
Channel 1
Date
Thu, 06.05.2021
Time
17:30 - 18:30
Seagen - Research to reality: Going further for patients with HER2+ metastatic breast cancer
Industry Satellite Symposia
Effective adverse event management in clinical practice (ID 362)
Lecture Time
17:55 - 18:05
Speakers
Session Name
Room
Channel 2
Date
Thu, 06.05.2021
Time
17:30 - 18:30
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world
Industry Satellite Symposia
From clinical trials to real-world effectiveness: Charting a new standard in HR+/HER2- breast cancer (ID 346)
Lecture Time
17:35 - 18:00
Room
Channel 1
Date
Thu, 06.05.2021
Time
17:30 - 18:30
Seagen - Research to reality: Going further for patients with HER2+ metastatic breast cancer
Industry Satellite Symposia
What’s the reality of daily life for patients with HER2+ metastatic breast cancer? (ID 363)
Lecture Time
18:05 - 18:13
Speakers
Session Name
Room
Channel 2
Date
Thu, 06.05.2021
Time
17:30 - 18:30
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world
Industry Satellite Symposia
Q&A discussion (ID 347)
Lecture Time
18:15 - 18:30
Speakers
Room
Channel 1
Date
Thu, 06.05.2021
Time
17:30 - 18:30